EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 246 filers reported holding EDITAS MEDICINE INC in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $450,419 | -36.7% | 57,746 | -33.2% | 0.02% | -37.0% |
| Q2 2023 | $711,739 | +35.3% | 86,481 | +101.1% | 0.03% | -18.2% |
| Q3 2022 | $526,000 | +57.5% | 43,002 | +52.2% | 0.03% | +175.0% |
| Q2 2022 | $334,000 | -33.9% | 28,261 | +6.5% | 0.01% | -40.0% |
| Q1 2022 | $505,000 | +16.9% | 26,548 | +63.1% | 0.02% | +5.3% |
| Q4 2021 | $432,000 | -57.4% | 16,273 | -34.0% | 0.02% | -67.2% |
| Q3 2021 | $1,013,000 | +21.5% | 24,670 | +24.2% | 0.06% | +41.5% |
| Q1 2021 | $834,000 | +69.5% | 19,860 | +13.2% | 0.04% | +78.3% |
| Q3 2020 | $492,000 | +12.3% | 17,544 | +18.5% | 0.02% | +4.5% |
| Q2 2020 | $438,000 | +52.6% | 14,808 | +2.3% | 0.02% | +4.8% |
| Q1 2020 | $287,000 | -52.0% | 14,482 | -28.3% | 0.02% | -19.2% |
| Q4 2019 | $598,000 | +134.5% | 20,200 | +80.0% | 0.03% | +100.0% |
| Q3 2019 | $255,000 | – | 11,224 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NIA IMPACT ADVISORS, LLC | 54,615 | $4,897,000 | 2.55% |
| Capital Impact Advisors, LLC | 130,000 | $9,114,000 | 2.24% |
| ARK Investment Management | 10,125,564 | $709,903,000 | 1.89% |
| Nikko Asset Management Americas, Inc. | 4,388,143 | $307,653,000 | 1.75% |
| Spectrum Planning & Advisory Services Inc. | 17,522 | $1,228,000 | 1.32% |
| DDD Partners, LLC | 79,527 | $5,576,000 | 1.10% |
| Brevan Howard Capital Management LP | 76,420 | $5,358,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 538,721 | $37,770,000 | 0.75% |
| DC Investments Management, LLC | 3,627 | $254,000 | 0.63% |
| Haafor (Singapore) Pte. Ltd. | 4,761 | $334,000 | 0.62% |